[1]
Ejlertsen, B. et al. 2014. Excess mortality in postmenopausal high-risk women who only receive adjuvant endocrine therapy for estrogen receptor positive breast cancer. Acta Oncologica. 53, 2 (Feb. 2014), 174–185. DOI:https://doi.org/10.3109/0284186X.2013.850738.